Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 8;16(3):100673.
doi: 10.1016/j.waojou.2022.100673. eCollection 2023 Mar.

DRESS syndrome: A literature review and treatment algorithm

Affiliations
Review

DRESS syndrome: A literature review and treatment algorithm

Ana María Calle et al. World Allergy Organ J. .

Abstract

Drug reaction with eosinophilia and systemic symptoms, known by its acronym in English as DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms), clinically manifests with fever, facial edema, lymphadenopathy, a morbilliform rash, and organ involvement. Laboratory results reveal leukocytosis, atypical lymphocytes, eosinophilia, and alterations of liver and kidney function tests. The actual incidence of DRESS is unknown, because it may vary depending on the type of medication and the immune status of each patient; also, because many cases remain undiagnosed or untreated. The drugs most associated with DRESS include antiepileptics, antibiotics, antituberculosis, and non-steroidal anti-inflammatory agents (NSAIDs). Its diagnosis is sometimes made late and can become a challenge. The diagnostic criteria proposed by the international Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) help to establish the diagnosis through a score system based on clinical and laboratory findings. The first step to identify the culprit is a thorough clinical history that includes all suspects, emphasizing those most known to cause DRESS syndrome according to the context and the literature. A skin biopsy may also be helpful in the diagnostic process. Patch testing is the test of choice to search for the culprit in cases of DRESS. Regarding prognosis, the estimated mortality due to DRESS is 3.8%. The main causes of mortality include fulminant hepatitis and liver necrosis. Several indicators of poor prognosis have been identified and these include an eosinophil count above 6000 × 103/μL, thrombocytopenia, pancytopenia, leukocytosis and coagulopathy. This article aims to review the evidence available regarding the epidemiology, pathophysiology, clinical and laboratory findings, diagnosis, and treatment of DRESS.

Keywords: DIHS; DRESS; Drug hypersensitivity; Drug reaction; Eosinophilia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Depicts the recommended treatment algorithm for DRESS syndrome. Initially there are some general recommendations for any DRESS syndrome case. The algorithm further discriminates the treatment based on the severity of each case depending on whether it is a non-sever or a severe case. This algorithm was modified from Cabañas R et al.

References

    1. Bocquet H., Bagot M., Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS) Semin Cutan Med Surg. 1996 Dec;15(4):250–257. - PubMed
    1. Husain Z., Reddy B.Y., Schwartz R.A. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol. 2013 May;68(5):693. e1–14; quiz 706–8. - PubMed
    1. Choudhary S., McLeod M., Torchia D., Romanelli P. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. J Clin Aesthet Dermatol. 2013 Jun;6(6):31–37. - PMC - PubMed
    1. Shiohara T., Kano Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management [Internet] Expert Opin Drug Saf. 2016:1–9. doi: 10.1080/14740338.2017.1270940. Available from: - DOI - PubMed
    1. Muller P., Dubreil P., Mahé A., et al. Drug hypersensitivity syndrome in a west-Indian population. Eur J Dermatol. 2003 Sep;13(5):478–481. - PubMed

LinkOut - more resources